Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 51 | 2023 | 222 | 9.800 |
Why?
|
| Melatonin | 42 | 2023 | 91 | 7.820 |
Why?
|
| Sleep | 53 | 2024 | 288 | 6.690 |
Why?
|
| Light | 18 | 2017 | 55 | 3.950 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 18 | 2021 | 46 | 3.630 |
Why?
|
| Sleep Wake Disorders | 13 | 2023 | 118 | 3.400 |
Why?
|
| Phototherapy | 10 | 2019 | 27 | 2.620 |
Why?
|
| Photoperiod | 10 | 2016 | 28 | 2.220 |
Why?
|
| Low Back Pain | 4 | 2020 | 128 | 1.800 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2023 | 221 | 1.580 |
Why?
|
| Adult | 56 | 2023 | 7662 | 1.540 |
Why?
|
| Saliva | 15 | 2018 | 48 | 1.440 |
Why?
|
| Chronic Pain | 4 | 2020 | 133 | 1.390 |
Why?
|
| Female | 66 | 2023 | 14734 | 1.390 |
Why?
|
| Humans | 88 | 2024 | 25967 | 1.380 |
Why?
|
| Lighting | 7 | 2016 | 12 | 1.370 |
Why?
|
| Actigraphy | 7 | 2023 | 98 | 1.280 |
Why?
|
| Male | 52 | 2023 | 14277 | 1.110 |
Why?
|
| Time Factors | 20 | 2018 | 1391 | 1.050 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2018 | 81 | 1.030 |
Why?
|
| Young Adult | 18 | 2020 | 1941 | 0.930 |
Why?
|
| HIV Infections | 4 | 2023 | 434 | 0.920 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2022 | 104 | 0.910 |
Why?
|
| Wrist | 2 | 2022 | 16 | 0.890 |
Why?
|
| Sleep Deprivation | 4 | 2012 | 41 | 0.830 |
Why?
|
| Surveys and Questionnaires | 12 | 2019 | 1107 | 0.800 |
Why?
|
| Affect | 5 | 2020 | 59 | 0.730 |
Why?
|
| Chronobiology Disorders | 2 | 2018 | 14 | 0.700 |
Why?
|
| Body Temperature | 9 | 2016 | 41 | 0.690 |
Why?
|
| Middle Aged | 18 | 2023 | 8772 | 0.680 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 179 | 0.670 |
Why?
|
| Wakefulness | 11 | 2016 | 69 | 0.640 |
Why?
|
| Depression | 3 | 2022 | 412 | 0.640 |
Why?
|
| Receptors, Melatonin | 2 | 2018 | 2 | 0.630 |
Why?
|
| Wearable Electronic Devices | 2 | 2019 | 44 | 0.620 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 72 | 0.600 |
Why?
|
| Hypnotics and Sedatives | 1 | 2018 | 20 | 0.580 |
Why?
|
| Sleep Hygiene | 1 | 2017 | 5 | 0.570 |
Why?
|
| Pain Management | 1 | 2019 | 141 | 0.550 |
Why?
|
| Fibromyalgia | 1 | 2017 | 27 | 0.520 |
Why?
|
| Photic Stimulation | 2 | 2016 | 23 | 0.520 |
Why?
|
| Adolescent | 11 | 2018 | 2099 | 0.500 |
Why?
|
| Housing | 1 | 2016 | 17 | 0.490 |
Why?
|
| Migraine Disorders | 3 | 2022 | 19 | 0.490 |
Why?
|
| Ethanol | 2 | 2016 | 82 | 0.490 |
Why?
|
| Central Nervous System Agents | 1 | 2015 | 7 | 0.480 |
Why?
|
| Chronobiology Phenomena | 1 | 2015 | 3 | 0.480 |
Why?
|
| Jet Lag Syndrome | 5 | 2021 | 11 | 0.480 |
Why?
|
| Acute Pain | 3 | 2020 | 23 | 0.470 |
Why?
|
| Pilot Projects | 5 | 2019 | 390 | 0.470 |
Why?
|
| Wakefulness-Promoting Agents | 1 | 2014 | 1 | 0.460 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 3 | 0.460 |
Why?
|
| Occupational Health | 1 | 2014 | 17 | 0.450 |
Why?
|
| Automobile Driving | 1 | 2014 | 20 | 0.450 |
Why?
|
| Seasons | 1 | 2014 | 22 | 0.450 |
Why?
|
| Motor Skills | 1 | 2014 | 45 | 0.450 |
Why?
|
| Patient Compliance | 2 | 2015 | 149 | 0.450 |
Why?
|
| Catastrophization | 3 | 2019 | 23 | 0.440 |
Why?
|
| Attention | 1 | 2014 | 106 | 0.430 |
Why?
|
| Heart Rate | 4 | 2004 | 105 | 0.410 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 26 | 0.390 |
Why?
|
| Hypertension | 1 | 2012 | 181 | 0.350 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 33 | 0.340 |
Why?
|
| Polysomnography | 4 | 2022 | 73 | 0.330 |
Why?
|
| Intestinal Mucosa | 3 | 2015 | 155 | 0.320 |
Why?
|
| Activity Cycles | 1 | 2008 | 2 | 0.300 |
Why?
|
| Shift Work Schedule | 2 | 2018 | 7 | 0.290 |
Why?
|
| Pain Threshold | 2 | 2019 | 25 | 0.290 |
Why?
|
| Arousal | 2 | 2005 | 49 | 0.290 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 13 | 0.280 |
Why?
|
| Veterans | 2 | 2020 | 87 | 0.280 |
Why?
|
| Heart | 2 | 2005 | 59 | 0.280 |
Why?
|
| Social Support | 2 | 2018 | 190 | 0.270 |
Why?
|
| tau Proteins | 1 | 2008 | 225 | 0.270 |
Why?
|
| Autonomic Nervous System | 2 | 2004 | 19 | 0.260 |
Why?
|
| Quality of Life | 2 | 2022 | 605 | 0.260 |
Why?
|
| Adaptation, Physiological | 2 | 2005 | 43 | 0.250 |
Why?
|
| Self Report | 2 | 2017 | 217 | 0.240 |
Why?
|
| Parasympathetic Nervous System | 1 | 2005 | 2 | 0.240 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2005 | 10 | 0.240 |
Why?
|
| Endotoxemia | 2 | 2015 | 20 | 0.240 |
Why?
|
| Intestinal Absorption | 2 | 2015 | 30 | 0.230 |
Why?
|
| Cell Membrane Permeability | 2 | 2015 | 52 | 0.230 |
Why?
|
| Anxiety | 3 | 2022 | 146 | 0.230 |
Why?
|
| Seasonal Affective Disorder | 1 | 2004 | 1 | 0.220 |
Why?
|
| Cardiography, Impedance | 1 | 2004 | 2 | 0.220 |
Why?
|
| Darkness | 3 | 2010 | 7 | 0.220 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 851 | 0.210 |
Why?
|
| Neurotic Disorders | 1 | 2002 | 19 | 0.200 |
Why?
|
| Kynurenine | 1 | 2022 | 1 | 0.200 |
Why?
|
| Critical Care | 1 | 2024 | 113 | 0.200 |
Why?
|
| Pain Measurement | 3 | 2020 | 476 | 0.200 |
Why?
|
| Biomarkers | 3 | 2016 | 544 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2024 | 248 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 125 | 0.190 |
Why?
|
| Work Schedule Tolerance | 2 | 2016 | 24 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2001 | 54 | 0.180 |
Why?
|
| Volatilization | 1 | 2020 | 4 | 0.170 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 307 | 0.160 |
Why?
|
| Military Personnel | 1 | 2019 | 38 | 0.150 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 160 | 0.150 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 2 | 2016 | 8 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 328 | 0.150 |
Why?
|
| Period Circadian Proteins | 1 | 2018 | 13 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2020 | 3399 | 0.140 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 13 | 0.140 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2016 | 15 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2018 | 82 | 0.140 |
Why?
|
| Urban Population | 1 | 2018 | 149 | 0.140 |
Why?
|
| Specimen Handling | 2 | 2015 | 40 | 0.130 |
Why?
|
| Fluoxetine | 1 | 2017 | 34 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2017 | 100 | 0.130 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 90 | 0.130 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 93 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 37 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2016 | 31 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2008 | 449 | 0.120 |
Why?
|
| Administration, Oral | 1 | 2016 | 104 | 0.120 |
Why?
|
| United States | 2 | 2019 | 1989 | 0.120 |
Why?
|
| Colon | 1 | 2016 | 111 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2015 | 55 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 121 | 0.120 |
Why?
|
| Risk Factors | 2 | 2018 | 2237 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2014 | 19 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 240 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 160 | 0.110 |
Why?
|
| Occupations | 1 | 2014 | 18 | 0.110 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 16 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 1333 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2015 | 252 | 0.110 |
Why?
|
| Sleep Stages | 2 | 2012 | 19 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 252 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 294 | 0.110 |
Why?
|
| Liver | 1 | 2014 | 143 | 0.100 |
Why?
|
| Biological Clocks | 2 | 2011 | 12 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 649 | 0.100 |
Why?
|
| HIV | 2 | 2023 | 39 | 0.100 |
Why?
|
| Sleep, REM | 2 | 2004 | 13 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3358 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2004 | 184 | 0.090 |
Why?
|
| Aged | 3 | 2020 | 8732 | 0.080 |
Why?
|
| Sex Factors | 2 | 2017 | 454 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2010 | 63 | 0.080 |
Why?
|
| Cognition | 3 | 2023 | 1250 | 0.080 |
Why?
|
| Iris | 1 | 2009 | 2 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 393 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2020 | 210 | 0.070 |
Why?
|
| Kinetics | 1 | 2008 | 178 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 181 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 868 | 0.070 |
Why?
|
| Child | 3 | 2015 | 1217 | 0.060 |
Why?
|
| Antioxidants | 1 | 2005 | 60 | 0.060 |
Why?
|
| Permeability | 2 | 2016 | 96 | 0.060 |
Why?
|
| Aviation | 1 | 2005 | 3 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2005 | 78 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 39 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 76 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2003 | 52 | 0.050 |
Why?
|
| Family | 1 | 2024 | 93 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 2003 | 4 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2023 | 18 | 0.050 |
Why?
|
| Rest | 1 | 2003 | 32 | 0.050 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2022 | 4 | 0.050 |
Why?
|
| Tryptophan | 1 | 2022 | 10 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 39 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 63 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2002 | 6 | 0.050 |
Why?
|
| Overweight | 1 | 2023 | 69 | 0.050 |
Why?
|
| Sports | 1 | 2003 | 58 | 0.050 |
Why?
|
| Amygdala | 1 | 2022 | 41 | 0.050 |
Why?
|
| Psychotherapy | 1 | 2022 | 38 | 0.050 |
Why?
|
| Headache | 1 | 2022 | 37 | 0.050 |
Why?
|
| Arrhythmia, Sinus | 1 | 2001 | 2 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 211 | 0.050 |
Why?
|
| Respiration | 1 | 2001 | 30 | 0.050 |
Why?
|
| Rectum | 1 | 2001 | 50 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 169 | 0.040 |
Why?
|
| Foot | 1 | 2001 | 43 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2001 | 94 | 0.040 |
Why?
|
| Yoga | 1 | 2020 | 10 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 10 | 0.040 |
Why?
|
| Obesity | 1 | 2023 | 297 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 62 | 0.040 |
Why?
|
| Mindfulness | 1 | 2020 | 46 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2019 | 73 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 75 | 0.040 |
Why?
|
| Psychology | 1 | 2018 | 21 | 0.040 |
Why?
|
| Mice | 2 | 2014 | 1352 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 20 | 0.040 |
Why?
|
| Psychological Tests | 1 | 2018 | 50 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4641 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 476 | 0.040 |
Why?
|
| Genes | 1 | 2018 | 6 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 7 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 404 | 0.040 |
Why?
|
| Emotions | 1 | 2018 | 72 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 54 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 296 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 254 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 171 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 327 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 61 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 366 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 227 | 0.030 |
Why?
|
| Sleep Medicine Specialty | 1 | 2015 | 3 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 66 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 898 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Personality Assessment | 1 | 2015 | 33 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 10 | 0.030 |
Why?
|
| Animals | 2 | 2014 | 3503 | 0.030 |
Why?
|
| Immunoassay | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 65 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 96 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 2014 | 14 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 266 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 92 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2014 | 94 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 78 | 0.030 |
Why?
|
| Cues | 1 | 2013 | 38 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 575 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2014 | 597 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 577 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 571 | 0.020 |
Why?
|
| Schools | 1 | 2011 | 38 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 65 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 89 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2011 | 38 | 0.020 |
Why?
|
| Circadian Clocks | 1 | 2011 | 20 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1701 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 58 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 6 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 466 | 0.020 |
Why?
|
| MMPI | 1 | 2005 | 3 | 0.010 |
Why?
|
| Time | 1 | 2005 | 14 | 0.010 |
Why?
|
| Personality | 1 | 2005 | 51 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 175 | 0.010 |
Why?
|
| Reaction Time | 1 | 2003 | 91 | 0.010 |
Why?
|
| Pressure | 1 | 2002 | 63 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2002 | 80 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 1150 | 0.010 |
Why?
|